NO20042604L - Behandling av mikroorganismeinfeksjoner - Google Patents

Behandling av mikroorganismeinfeksjoner

Info

Publication number
NO20042604L
NO20042604L NO20042604A NO20042604A NO20042604L NO 20042604 L NO20042604 L NO 20042604L NO 20042604 A NO20042604 A NO 20042604A NO 20042604 A NO20042604 A NO 20042604A NO 20042604 L NO20042604 L NO 20042604L
Authority
NO
Norway
Prior art keywords
treatment
microorganism infections
antibody
infections
microorganism
Prior art date
Application number
NO20042604A
Other languages
English (en)
Norwegian (no)
Inventor
James Peter Burnie
Ruth Christne Matthews
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Publication of NO20042604L publication Critical patent/NO20042604L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20042604A 2001-11-22 2004-06-21 Behandling av mikroorganismeinfeksjoner NO20042604L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127983.5A GB0127983D0 (en) 2001-11-22 2001-11-22 Treatment of micro-organism infection
PCT/GB2002/005135 WO2003046007A2 (en) 2001-11-22 2002-11-13 Treatment of micro-organism infection

Publications (1)

Publication Number Publication Date
NO20042604L true NO20042604L (no) 2004-06-21

Family

ID=9926237

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20042604A NO20042604L (no) 2001-11-22 2004-06-21 Behandling av mikroorganismeinfeksjoner
NO20081575A NO20081575L (no) 2001-11-22 2008-03-31 Behandling av mikroorganismeinfeksjoner

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20081575A NO20081575L (no) 2001-11-22 2008-03-31 Behandling av mikroorganismeinfeksjoner

Country Status (18)

Country Link
US (3) US20050118162A1 (de)
EP (2) EP1446425B1 (de)
JP (1) JP2005511645A (de)
CN (2) CN101254304A (de)
AT (1) ATE427320T1 (de)
AU (2) AU2002339159B2 (de)
BR (1) BR0214363A (de)
CA (1) CA2465072A1 (de)
DE (1) DE60231825D1 (de)
DK (1) DK1446425T3 (de)
ES (1) ES2322756T3 (de)
GB (1) GB0127983D0 (de)
NO (2) NO20042604L (de)
NZ (1) NZ533623A (de)
PL (1) PL369536A1 (de)
PT (1) PT1446425E (de)
RU (1) RU2303460C2 (de)
WO (1) WO2003046007A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5248033B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
JP5248032B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
WO2008132174A1 (en) * 2007-04-27 2008-11-06 Novartis Ag An immunoglobulin composition
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
MX2011012248A (es) 2009-05-18 2012-02-29 Univ Wuerzburg J Maximilians Anticuerpos o sus fragmentos dirigidos contra un epitope de staphylococcus aureus de isaa o isab.
JP6192294B2 (ja) * 2009-07-15 2017-09-06 エーアイエムエム セラピューティクス ベー．フェー． グラム陽性菌特異的結合化合物
US9005579B2 (en) * 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
JP5996544B2 (ja) 2010-10-15 2016-09-21 クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 眼球アクセス用装置
CN103168046A (zh) * 2010-10-20 2013-06-19 米迪缪尼有限公司 用于加工包涵体的方法
BR112015027762A2 (pt) 2013-05-03 2017-08-29 Clearside Biomedical Inc Aparelho e métodos para injeção ocular
RU2572341C2 (ru) * 2013-09-20 2016-01-10 Федеральное государственное бюджетное учреждение Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе Российской академии медицинских наук (ФГБУ "НИИНА" РАМН) АНТИБИОТИК ИНА 5812, ШТАММ-ПРОДУЦЕНТ Streptomyces roseoflavus ИНА-Ас-5812 И СПОСОБ ПОЛУЧЕНИЯ АНТИБИОТИКА
EP3452165A1 (de) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systeme und verfahren zur verabreichung eines augenmedikaments
IL305537B2 (en) 2016-08-12 2025-02-01 Clearside Biomedical Inc Devices and methods for adjusting the insertion depth of a needle for administering a drug
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0779819A1 (de) * 1994-09-06 1997-06-25 Galagen Inc. Therapeutische behandlung von clostridium difficile verbundene krankheiten
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
GB9806762D0 (en) 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection

Also Published As

Publication number Publication date
PL369536A1 (en) 2005-05-02
CN101254304A (zh) 2008-09-03
RU2004118716A (ru) 2005-03-27
US20050118162A1 (en) 2005-06-02
ATE427320T1 (de) 2009-04-15
RU2303460C2 (ru) 2007-07-27
WO2003046007A2 (en) 2003-06-05
AU2002339159A1 (en) 2003-06-10
ES2322756T3 (es) 2009-06-26
EP1446425B1 (de) 2009-04-01
PT1446425E (pt) 2009-07-01
AU2008212001A1 (en) 2008-09-25
DK1446425T3 (da) 2009-07-20
US20070202116A1 (en) 2007-08-30
WO2003046007A3 (en) 2004-03-11
NZ533623A (en) 2005-12-23
GB0127983D0 (en) 2002-01-16
EP1964851A1 (de) 2008-09-03
NO20081575L (no) 2004-06-21
BR0214363A (pt) 2004-10-26
EP1446425A2 (de) 2004-08-18
CA2465072A1 (en) 2003-06-05
CN1589280A (zh) 2005-03-02
US20080171054A1 (en) 2008-07-17
AU2002339159B2 (en) 2008-06-05
CN100371348C (zh) 2008-02-27
DE60231825D1 (de) 2009-05-14
JP2005511645A (ja) 2005-04-28

Similar Documents

Publication Publication Date Title
NO20081575L (no) Behandling av mikroorganismeinfeksjoner
DE60224508D1 (de) Wti-modifiziertes peptid
DE60322188D1 (de) Zytokin (zcytor17-ligand)
BR0209434A (pt) Peptìdeos antimicrobianos e composições
FR2792202B1 (fr) Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
RU94046091A (ru) Полипептидные антагонисты бомбезина, фармацевтическая композиция и способ лечения
NO20013905D0 (no) Lantibiotika
ATE403726T1 (de) Cytokin-proteinfamilie
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
GB0203419D0 (en) Peptide
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
WO1999057142A3 (en) Vaccine for $i(pseudomonas aeruginosa)
LT2002123A (en) Novel interferon for the treatment of multiple sclerosis
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
ATE514716T1 (de) Fragmente toxin-bezogener antikörper, mit antimikrobieller und antiviraler aktivität
WO2002085934A3 (fr) Peptides antibacteriens, les compositions les contenant et leurs utilisations
NZ591827A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
NZ508812A (en) Peptides for the prevention or treatment of HIV
WO2001058471A3 (en) Novel amino acid and peptide inhibitors of staphylococcus virulence
ATE305941T1 (de) Impfstoff
WO2003027274A3 (en) Purified polypeptides from pseudomonas aeruginosa
MY143402A (en) Preparations used in the treatment and prophilaxis of mycobacterial infections
CO4820441A1 (es) Antigeno bm 95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinantes, microorganismos transformados y preparacion vacunal
WO2004041856A3 (en) Crystal structures of bacterial inorganic pyrophosphatases
WO2004058811A3 (en) Crystal structures of yhhf polypeptides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application